Q2 EPS Estimates for Kymera Therapeutics Raised by B. Riley
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) – Equities researchers at B. Riley lifted their Q2 2025 earnings per share (EPS) estimates for shares of Kymera Therapeutics in a research report issued to clients and investors on Monday, May 12th. B. Riley analyst K. Patel now expects that the company will earn ($1.01) per share […]
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) – Equities researchers at B. Riley lifted their Q2 2025 earnings per share (EPS) estimates for shares of Kymera Therapeutics in a research report issued to clients and investors on Monday, May 12th. B. Riley analyst K. Patel now expects that the company will earn ($1.01) per share […]
